Category: Avicanna

Avicanna Enters Agreement to Develop and License Cannabinoid Tablet Formulations for US Distributor Partner
Avicanna’s RHO Phyto™ Rapid Act Sprays are Now Available Nation Wide in Canada Through Medical Cannabis by Shoppers™
Avicanna’s Subsidiary Obtains GPP Certification and Authorization By INVIMA For The Compounding and Sale Of Pharmaceutical Cannabinoid Products With Medical Prescriptions In Colombia
Avicanna Advances its Supply Chain Business with Commercial Exports of CBG And CBD into the United States and Germany as well as Industrial Scale THC Quota Granted by the Colombian Authorities
Avicanna Closes Non-Brokered Private Placement Raising $2.7 Million
Avicanna Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Avicanna’s RHO Phyto™ Medical Product Line is Now Available Nation-Wide in Canada Through Medical Cannabis by Shoppers Inc.
Avicanna and Red White & Bloom enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States
Avicanna Inc. to Host Second Quarter 2020 Investor Conference Call
Avicanna announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph